Signify Health, Inc. (NYSE: SGFY) achieved an average “Hold” recommendation of the eleven rating companies that currently hedge the stock, reports MarketBeat. One research analyst rated the stock with a sell recommendation, four issued a hold recommendation, and six issued a buy recommendation on the company. The 12-month average price target among analysts who hedged the stock in the past year is $ 31.22.
Several equity analysts have commented on SGFY shares. Zacks Investment Research downgraded Signify Health shares from a “hold” rating to a “sell” rating in a research report released on Friday, November 12. Deutsche Bank Aktiengesellschaft cut its target price on Signify Health shares from $ 36.00 to $ 31.00 and set a “buy” note for the company in a research note on Monday, November 15. Cowen assumed coverage of Signify Health shares in a research note on Thursday, September 9. They issued a “market performance” rating and a target price of $ 27.00 for the company. Piper Sandler lowered her price target on Signify Health shares from $ 42.00 to $ 34.00 and set an “overweight” rating for the company in a research note on Thursday, November 11. Finally, Robert W. Baird downgraded Signify Health shares from an “outperforming” rating to a “neutral” rating and lowered their target price for the stock from $ 30.00 to $ 24.00 in a report. published on Thursday 23 September.
SGFY opened at $ 14.22 on Friday. The company has a debt to equity ratio of 0.23, a quick ratio of 5.55, and a current ratio of 5.55. Signify Health has a one-year low at $ 12.67 and a one-year high at $ 40.79. The company has a 50-day moving average price of $ 14.87 and a two-hundred-day moving average price of $ 21.85.
Signify Health (NYSE: SGFY) last released its results on Tuesday, November 9. The company reported earnings per share (EPS) of $ 0.12 for the quarter, beating the Zacks’ consensus estimate of $ 0.03 by $ 0.09. The company posted revenue of $ 199.20 million in the quarter, compared to analysts’ estimates of $ 185.04 million. Signify Health recorded a positive return on equity of 5.78% and a negative net margin of 2.23%. Sell-side analysts predict Signify Health will post 0.31 EPS for the current year.
Separately, insider Steve Senneff bought 2,500 shares of the company in a trade that took place on Monday, November 22. The shares were purchased at an average cost of $ 13.27 per share, for a total value of $ 33,175.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Institutional investors and hedge funds recently bought and sold shares in the company. Allen Investment Management LLC purchased a new position in Signify Health shares in the third quarter valued at approximately $ 419,000. FMR LLC increased its stake in Signify Health shares by 4.0% in the second quarter. FMR LLC now owns 2,063,421 shares of the company valued at $ 62,790,000 after purchasing an additional 78,959 shares during the last quarter. Nikko Asset Management Americas Inc. purchased a new position in Signify Health shares in the second quarter valued at approximately $ 12,713,000. Parametric Portfolio Associates LLC purchased a new position in Signify Health shares in the second quarter valued at approximately $ 421,000. Finally, Citigroup Inc. increased its stake in Signify Health shares by 66.6% in the second quarter. Citigroup Inc. now owns 3,347 shares of the company valued at $ 102,000 after purchasing an additional 1,338 shares in the last quarter.
Signify Health Company Profile
Signify Health, Inc operates a healthcare platform that utilizes healthcare analytics, technology, and provider networks in the United States. The company operates in two segments, home and community services and episode of care services. The Home and Community Services segment offers health assessments performed at the patient’s home or in a health care facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address health issues related to the social determinants of health.
Featured Story: Dogs of the Dow Jones
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]
Should you invest $ 1,000 in Signify Health now?
Before you consider Signify Health, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly asking their clients to buy now before the broader market takes hold … and Signify Health was not on the list.
While Signify Health currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bets.
See the 5 actions here